Tag: Alzheimer’s treatment
Alzheimer’s Drug Developers Accuse Clinical Trial Sites of Faking Data
From Science.org. "T3D Therapeutics alleges that contract researchers delivered “medically impossible” results on its candidate drug.
In 2023, the drug developer T3D Therapeutics glimpsed a...
Ethical Issues Raised Over FDA Collaboration with Biogen on Failed Drug
The FDA collaborated with Biogen to conduct repeated re-analyses of aducanumab for Alzheimer's and FDA committee members are raising concerns.
Biogen Pushes FDA to Approve Failed Alzheimer’s Drug
A new analysis, published in Lancet Neurology, demonstrates how Biogen is spinning results from two failed trials for a new Alzheimer's drug.
